Although the Vik et al. study did not stratify the risk of breast cancer relative to OPG levels according to ER status, it is likely that both studies are in agreement that low OPG serum levels are associated with reduced risk of ER+ breast cancer, whilst higher OPG serum levels are associated with increased risk of ER− breast cancer. The gene discussed is TNFRSF11B; the disease is breast cancer.